Macfos Limited has scheduled a board meeting on March 11, 2026, to discuss the allotment of bonus equity shares following the successful completion of the postal ballot process where shareholders unanimously approved the bonus share issue in the ratio of 1:10.

Board Meeting and Allotment Timeline

The company has informed BSE Limited about the upcoming board meeting under Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The meeting will be held at the registered office of the company to pass a resolution for the allotment of bonus equity shares.

Postal Ballot Approval Details

The postal ballot, concluded on February 28, 2026, received unanimous shareholder approval for issuing bonus shares in the ratio of 1:10, meaning shareholders will receive one additional equity share for every ten shares currently held. The company plans to capitalize ₹94,16,820 from its securities premium account to fund this bonus issue.

Regulatory Compliance and Implementation

In accordance with SEBI circular dated September 16, 2024, the deemed date of allotment will be March 11, 2026, with bonus shares becoming available for trading on March 12, 2026. The company secretary CS Sagar Gulhane has communicated the board meeting details to BSE Limited under the prescribed regulatory framework.

The approved bonus shares will be allotted in dematerialized form only and credited directly to shareholders' demat accounts. These bonus shares will rank pari passu with existing equity shares, carrying the same rights and privileges. For foreign investors including NRIs and FIIs, the allotment remains subject to regulatory approvals from RBI and other relevant authorities.

Next Steps

Following the board meeting on March 11, 2026, the company will complete all necessary formalities for implementing the bonus issue, including listing the additional shares on BSE Limited. The postal ballot was conducted under the supervision of CS Vipin Zavar from CZ & Associates LLP, who served as the scrutinizer to ensure the integrity of the voting process.

Macfos Limited has announced that its Board of Directors will convene on January 28, 2026, at the company's registered office to deliberate on key financial matters and corporate actions. The meeting has been scheduled in compliance with Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Board Meeting Agenda

The board meeting will address two primary items that are crucial for shareholders and market participants. The directors will review the company's financial performance and consider a significant corporate action that could impact shareholding patterns.

Trading Window Status

Macfos Limited has implemented trading restrictions in accordance with regulatory guidelines to ensure fair market practices during the financial results period. The company had previously communicated these restrictions to maintain transparency with market participants.

The trading window for dealing in the company's securities remains closed from January 1, 2026, as per the intimation dated December 29, 2025. The window will reopen 48 hours after the declaration of financial results, ensuring compliance with insider trading regulations.

Regulatory Compliance

The board meeting notification has been submitted to BSE Limited under the company's scrip code ROBU (543787). CS Sagar Gulhane, Company Secretary and Compliance Officer (ACS-67610), has signed the official communication to the exchange, ensuring proper regulatory adherence.

The meeting represents a significant milestone for Macfos Limited as it prepares to announce its third-quarter performance for FY26 and potentially enhance shareholder value through the proposed bonus share issue, subject to necessary approvals and regulatory clearances.